Summary
The paper discusses the use of Lycium barbarum polysaccharides (LBP) and FDA-approved small molecules in promoting nerve repair and visual function recovery in cases of peripheral nerve injury and optic nerve crush, and their potential application in treating nervous system injuries.
Categories
Dementia: The paper mentions the neuroprotective effects of LBP in neurodegenerative diseases such as Alzheimer’s disease.
Cognitive function and memory: The paper discusses the potential of LBP and FDA-approved small molecules in promoting nerve repair, which could have implications for cognitive function and memory.
Eye health: The paper focuses on the use of LBP and FDA-approved small molecules in promoting retinal ganglion cell survival and optic nerve regeneration, which are crucial for eye health.
Aging: The paper discusses the potential of LBP and FDA-approved small molecules in promoting nerve repair and function recovery, which could have implications for aging-related neurodegenerative diseases.
Phototherapy: The paper discusses the use of LBP, a compound derived from a plant, in promoting nerve repair and function recovery, which could be considered a form of phototherapy.
Author(s)
NPB Au, G Kumar, P Asthana, F Gao
Publication Year
2022
Number of Citations
12
Related Publications
Dementia
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The effects of light and the circadian system on rhythmic brain function
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency